Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Mar;68(3):765-71.
doi: 10.1086/318806. Epub 2001 Feb 8.

Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma)

S Aradhya  1 , G Courtois, A Rajkovic, R A Lewis, M Levy, A Israël, D L Nelson
Affiliations

Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma)

S Aradhya et al. Am J Hum Genet. 2001 Mar.

Abstract

Familial incontinentia pigmenti (IP [MIM 308310]), or Bloch-Sulzberger syndrome, is an X-linked dominant and male-lethal disorder. We recently demonstrated that mutations in NEMO (IKK-gamma), which encodes a critical component of the NF-kappaB signaling pathway, were responsible for IP. Virtually all mutations eliminate the production of NEMO, causing the typical skewing of X inactivation in female individuals and lethality in male individuals, possibly through enhanced sensitivity to apoptosis. Most mutations also give rise to classic signs of IP, but, in this report, we describe two mutations in families with atypical phenotypes. Remarkably, each family included a male individual with unusual signs, including postnatal survival and either immune dysfunction or hematopoietic disturbance. We found two duplication mutations in these families, at a cytosine tract in exon 10 of NEMO, both of which remove the zinc (Zn) finger at the C-terminus of the protein. Two deletion mutations were also identified in the same tract in additional families. However, only the duplication mutations allowed male individuals to survive, and affected female individuals with duplication mutations demonstrated random or slight skewing of X inactivation. Similarly, NF-kappaB activation was diminished in the presence of duplication mutations and was completely absent in cells with deletion mutations. These results strongly indicate that male individuals can also suffer from IP caused by NEMO mutations, and we therefore urge a reevaluation of the diagnostic criteria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mutation analysis of NEMO exon 10. A, CSGE bandshifts in affected members. B, Sequence analysis reveals mixed sequence (arrows indicate start point) due to mutations. C, DNA-sequence alignments between normal and mutant exon-10 sequences, with the cytosine tract at the left. Arrows point to mutations, and blue boxes mark the duplications. D, Protein-sequence alignments show the addition of novel amino acids, enclosed in blue boxes. Orange boxes indicate stop codon positions. E, Mutational mechanism at the cytosine tract, with duplications (1, 3) on top and deletions (2, 4) at the bottom.
Figure 2
Figure 2
Analysis of NEMO activity by means of a genetic complementation assay in a NEMO-minus cell line. A, Expression analyses with various NEMO cDNA constructs were performed in six trials; the average luciferase-expression values are shown. Specific mutations introduced into the NEMO cDNA are indicated below the chart. The ΔC1161 deletion shows complete absence of complementation activity (same as background). In contrast, the duplication mutations, dupC1161 and dup1166-78, show diminished and residual activities. B, In vitro translation experiment confirms both the expected smaller protein sizes due to the duplication mutations and a larger protein size with the ΔC1161 mutation.
Figure 3
Figure 3
X-inactivation analysis in pedigrees with exon-10 mutations. The methylation-based assay detects the active X chromosome after digestion with a methylation-sensitive enzyme, HpaII (H). Two bands in the “H” lanes indicate random X inactivation, and a single band suggests complete skewing of X inactivation. The RsaI (R) digest serves as control, and both alleles are amplified. A, Affected members with the ΔC1161 mutation show complete skewing of X inactivation. B, Patients with the dupC1161 mutation show random X inactivation. C, Affected female subjects with the dup1166-78 mutation in family XL320 show mild skewing (∼60%) of X inactivation. D, Family XL374 has the Δ1163-75 mutation, which causes complete skewing in affected members.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Electronic-Database Information

    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim (for IP [MIM 308310]; for X-linked anhidrotic ectodermal dysplasia [MIM 305100]; for autosomal recessive hypohidrotic ectodermal dysplasia [MIM 224900]; for autosomal dominant hidrotic ectodermal dysplasia [MIM 129500]; for primary congenital lymphedema [MIM 153100]); for Partington syndrome II [MIM 301220]; and for Goltz syndrome [MIM 305600])

References

    1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229–1239 - PMC - PubMed
    1. Barkett M, Gilmore TD (1999) Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18:6910–6924 - PubMed
    1. Courtois G, Whiteside ST, Sibley CH, Israel A (1997) Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli. Mol Cell Biol 17:1441–1449 - PMC - PubMed
    1. Dahl MV, Matula G, Leonards R, Tuffanelli DL (1975) Incontinentia pigmenti and defective neutrophil chemotaxis. Arch Dermatol 111:1603–1605 - PubMed
    1. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548–554 - PubMed

Publication types